至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging.

Cell. 2017; 
BaarMarjolein P,BrandtRenata M C,PutavetDiana A,KleinJulian D D,DerksKasper W J,BourgeoisBenjamin R M,StryeckSarah,RijksenYvonne,van WilligenburgHester,FeijtelDanny A,van der PluijmIngrid,EssersJeroen,van CappellenWiggert A,van IJckenWilfred F,HoutsmullerAdriaan B,PothofJoris,de BruinRon W F,MadlTobias,HoeijmakersJan H J,CampisiJudith,de KeizerPeter
Products/Services Used Details Operation
PCR Cloning and Subcloning The constructs corresponding to human FOXO4 (residues 86 – 206) and human p53 (residues 1 – 312), were purchased from Genscript in a pUC cloning vector. Get A Quote

摘要

The accumulation of irreparable cellular damage restricts healthspan after acute stress or natural aging. Senescent cells are thought to impair tissue function, and their genetic clearance can delay features of aging. Identifying how senescent cells avoid apoptosis allows for the prospective design of anti-senescence compounds to address whether homeostasis can also be restored. Here, we identify FOXO4 as a pivot in senescent cell viability. We designed a FOXO4 peptide that perturbs the FOXO4 interaction with p53. In senescent cells, this selectively causes p53 nuclear exclusion and cell-intrinsic apoptosis. Under conditions where it was well tolerated in vivo, this FOXO4 peptide neutralized doxorub... More

关键词

FOXO4,IL6,LMNB1,Senescence,TP53,aging,apoptosis,cell-penetrating peptide,chemotherapy,tissue homeost